FIELD: dermatology. SUBSTANCE: corticosteroid hormones are administered to patient. Simultaneously, to prevent complications, collalysine is injected intramuscularly additionally to patient in daily dose 500-750 units KE once a day for 10-15 days. EFFECT: enhanced efficiency of treatment.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIAGNOSING GONORRHEA | 1991 |
|
RU2029954C1 |
| METHOD FOR TREATING THE CASES OF LUPUS ERYTHEMATOSUS | 1998 |
|
RU2158129C2 |
| METHOD FOR TREATMENT OF ACANTHOLYTIC PEMPHIGUS | 2003 |
|
RU2233163C1 |
| METHOD OF TREATING IDIOPATIC DERMATOMYOSITIS | 0 |
|
SU1009468A1 |
| METHOD FOR TREATING PATIENTS FOR ACANTHOLYTIC BLADDERWORT | 2006 |
|
RU2321395C1 |
| METHOD FOR PREDICTING ACANTHOLYTIC PEMPHIGUS RECURRENCE | 2001 |
|
RU2199127C1 |
| METHOD OF TREATMENT OF PATIENTS WITH LICHEN ACUMINATUS | 2000 |
|
RU2192250C2 |
| METHOD FOR PROGNOSTICATING PROGRESS OF PSORIATIC ARTHRITIS | 1991 |
|
RU2032379C1 |
| METHOD FOR TREATING THE CASES OF NEURODERMITE | 1994 |
|
RU2099061C1 |
| METHOD FOR EVALUATING SEVERITY DEGREE OF PSORIASIS FLOW | 2000 |
|
RU2187116C2 |
